1. Academic Validation
  2. Novel analogues of istaroxime, a potent inhibitor of Na+,K+-ATPase: synthesis and structure-activity relationship

Novel analogues of istaroxime, a potent inhibitor of Na+,K+-ATPase: synthesis and structure-activity relationship

  • J Med Chem. 2008 Aug 14;51(15):4601-8. doi: 10.1021/jm800257s.
Mauro Gobbini 1 Silvia Armaroli Leonardo Banfi Alessandra Benicchio Giulio Carzana Giorgio Fedrizzi Patrizia Ferrari Giuseppe Giacalone Michele Giubileo Giuseppe Marazzi Rosella Micheletti Barbara Moro Marco Pozzi Piero Enrico Scotti Marco Torri Alberto Cerri
Affiliations

Affiliation

  • 1 Department of Medicinal Chemistry, Prassis Istituto di Ricerche Sigma-Tau SpA, Via Forlanini 3, Settimo Milanese, MI, Italy. mauro.gobbini@prassis.it
Abstract

We report the synthesis and biological properties of novel inhibitors of the Na(+),K(+)-ATPase as positive inotropic compounds. Following our previously described model from which Istaroxime was generated, the 5alpha,14alpha-androstane skeleton was used as a scaffold to study the space around the basic chain of our lead compound. Some compounds demonstrated higher potencies than Istaroxime on the receptor and the (E)-3-[(R)-3-pyrrolidinyl]oxime derivative, 15, was the most potent; as further confirmation of our model, the E isomers of the oxime are more potent than the Z form. The compounds tested in the guinea pig model induced positive inotropic effects, which are correlated to the in vitro inhibitory potency on the Na(+),K(+)-ATPase. The finding that all tested compounds resulted less proarrhythmogenic than digoxin, a currently clinically used positive inotropic agent, suggests that this could be a feature of the 3-aminoalkyloxime derivative class of 5alpha,14alpha-androstane.

Figures
Products